The effect of liposomal encapsulation of ampicillin on the antibacterial activity against intracellular Listeria monocytogenes was studied by comparing survival of L. monocytogenes within peritoneal mouse macrophages in the presence of free ampicillin alone or in combination with liposome-entrapped ampicillin. In the presence of 50 ,ug of free ampicillin per ml of the incubation medium, intracellular growth of L. monocytogenes was still observed, although less as compared with intracellular growth in the absence of ampicillin. At a concentration of 50 ,ug of free ampicillin plus 100 ,ug of liposome-entrapped ampicillin per ml, 99% of the intracellular bacteria were killed. On the other hand, a concentration of 150 ,ug of free ampicillin per ml plus empty liposomes only inhibited intracellular bacterial growth, and the bacteria were not killed. In addition, empty liposomes at a concentration of 1 ,umol of lipid per ml had no effect on intracellular bacterial growth. In broth, liposome-entrapped ampicillin at a concentration of 100 ,ug/mI was not bactericidal for L. monocytogenes, indicating that significant leakage of ampicillin from the liposomes with subsequent killing of the bacteria by the free drug did not occur. Therefore, we concluded that liposomal encapsulation of ampicillin results in an increased availability of the antibiotic for the intracellular bacteria.
Clinical experience has indicated that infections caused by intracellular bacteria are difficult to treat, especially in patients with underlying malignant disease or in patients receiving immunosuppressive drugs (18) . While the bacteria are susceptible to antibiotics in vitro, they seem to be protected from the action of antibiotics by their intracellular localization. The relative inefficiency of antibiotics in dealing with intracellular bacteria may be due to their poor penetration into cells. In a previous report it was shown that ampicillin in relatively high doses cured immunologically normal mice with infections due to the facultative intracellular bacterium Listeria monocytogenes (2) . In a recent study we observed a considerable enhancement (80-fold) in the therapeutic activity of ampicillin resulting from encapsulation of the antibiotic in liposomes (3) . We speculated that the mechanism by which the liposomes improved the therapeutic index of ampicillin was an increased delivery of the antibiotic to the liver and spleen, the organs infected with L. monocytogenes. Seventy-nine percent of the injected amount of liposome-entrapped ampicillin could be recovered from the liver and spleen. After isolating the Kupffer cells by pronase perfusion of the liver and subsequent elutriation centrifugation of the nonparenchymal cells, substantial amounts of radioactive liposomal ampicillin could be recovered from this cell type, the target cells of L. monocytogenes, after intravenous infusion (data not shown). In this study we investigated whether the enhancement of the therapeutic activity of liposome-entrapped ampicillin is also due to an increased availability of the drug inside the macrophages, the target cells of L. monocytogenes. We examined the effect of free versus liposome-entrapped ampicillin on the survival of L. monocytogenes in murine peritoneal macrophages in vitro.
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MATERIALS AND METHODS
Animals. Female C57Bl/Ka mice were used in all experiments. Mice were 11 to 13 weeks old and had been bred at REPGO-TNO Rijswijk, The Netherlands.
Bacteria. A serum-resistant strain of L. monocytogenes type 4b was used. The MIC of ampicillin (Beecham Research Laboratories, Amstelveen, The Netherlands) for this strain was 0.16 ,ug/ml by the tube dilution test. Bacteria were grown for 16 h at 37°C in Todd-Hewitt broth (Oxoid Ltd., London, England). This stationary-phase culture contained 2 x 109 CFU/ml (range, 1.8 x 109 to 2.2 x 109). Bacteria were washed twice in phosphate-buffered saline by centrifugation for 10 min at 3,500 x g. L. monocytogenes organisms (2 x 108 CFU/ml) were opsonized by incubation with 10% newborn calf serum (NCS) under continuous rotation at 8 rpm (rotating rack; Breda Scientific, Breda, The Netherlands) for 30 min at 37°C.
Preparation of liposomes. Multilamellar vesicles consisting of cholesterol, sphingomyelin, and L-a-phosphatidyl-Lserine in a molar ratio of 5:4:1 were prepared as described previously (3) . All liposome preparations were sized by extrusion through polycarbonate filters (final pore size, 0. 4 ,um) were recovered from the cell pellet, whereas 95 ± 0.6% (n = 3) of the liposomes not associated with the cells were recovered from the supernatant. Intracellular survival of L. monocytogenes. Cells were exposed to free ampicillin alone or in combination with either liposome-entrapped ampicillin or empty liposomes. Multilamellar vesicles were used at a concentration of 1 ,umol of vesicle lipid per ml of the incubation mixture. Control suspensions were incubated without ampicillin. At different time intervals the number of surviving intracellular L. monocytogenes was determined. In case the incubation occurred in the absence of free ampicillin, the extracellular bacteria were removed by centrifugation as described above. Small fractions of the cell suspensions were diluted 10-fold in cold distilled water containing 0.01% bovine serum albumin (Sigma Chemical Co., St. Louis, Mo.), 0.1% Triton X-100 (BDH, Poole, England), and 10 U of penicillinase SR106 (Oxoid) per ml. Triton X-100 was added to disrupt the liposomes. Penicillinase was added to inactivate the free ampicillin already present in the medium or broth to a concentration of 5 x 104 CFU/ml. After incubation for 2 h at 37°C, ampicillin, liposome-entrapped ampicillin, or empty liposomes were added at time zero. The numbers of viable organisms were then determined at regular time intervals over a 6-h period by plating 10-fold serial dilutions in saline onto blood-agar plates containing penicillinase.
RESULTS
Uptake of liposomes by peritoneal cells. Uptake of ["4C]ampicillin-labeled liposomes by peritoneal macrophages infected with L. monocytogenes was studied during a 6-h incubation period. Infected cells were incubated with liposomes containing 100 ,ug of ampicillin, to which trace amounts of ["4C]ampicillin had been added, plus 50 Rg of free ampicillin per ml. Separation of the L. monocytogenesinfected cells and the liposomes at time zero, as described above for uninfected cells, resulted in a recovery of 100 + 2.9% (n = 3) of the cells from the pellet, whereas 97 + 3.7% (n = 3) of the liposomes not associated with the cells were recovered from the supernatant. Uptake of ampicillincontaining liposomes by the cells increased up to 12% of the added dose after 6 h of incubation (Fig. 1) .
Effect After 30 min of phagocytosis in vivo, the number of ingested L. monocytogenes organisms was found to be 5.9 x 106 + 0.81 x 106 (100%) per 106 macrophages (n = 6). During the first 2 h of incubation of the macrophages in vitro, intracellular bacteria decreased in number to an average of 1.1 x 106 (19%) per 106 macrophages within 2 h (Fig. 2) .
From that time the number of intracellular L. monocytogenes increased about 27-fold within 4 h. In the presence of free ampicillin in combination with either empty liposomes or liposome-entrapped ampicillin during the first 2 h of incubation the initial mean number of intracellular L. monocytogenes decreased to an average of 1.5 x 106 (25%) per 106 macrophages, which was not significantly different from that of the controls. increased in the presence of free ampicillin, the total intracellular number was significantly (P < 0.01) less compared with that in untreated controls. In contrast to this intracellular bacterial multiplication, the addition of 100 jig of liposome-entrapped ampicillin in 1 ,umol of lipid to the concentration of 50 ,ug of free ampicillin per ml resulted in killing of more than 99% of intracellular L. monocytogenes. The lack of intracellular multiplication in the presence of liposome-entrapped ampicillin is reflected in the minimal decrease in number and viability of cells. After 12 h of incubation the number of cells was unchanged compared with the start of incubation, and there was no significant loss in cell viability (Table 1) Effect of liposome-entrapped ampicillin, free ampicillin, or empty liposomes on the growth of L. monocytogenes in broth. Intact ampicillin-containing liposomes did not affect the growth of L. monocytogenes in broth (Fig. 3) . The presence of 100 ,ug of ampicillin entrapped within liposomes at 1 ,umol of lipid per ml resulted in a slight delay in growth during the first 2 h, followed by a normal growth rate of the bacteria. Empty liposomes had no effect on the bacterial growth rate at all. These data, in combination with the observation that a concentration of 0.16 ,ug of free ampicillin per ml (the MBC) resulted in bacterial killing, demonstrate only a limited leakage (less than 0.2%) of ampicillin from the liposomes during the first 2 h.
DISCUSSION
The use of liposomes as carriers of therapeutic agents has been reviewed extensively by Gregoriadis (11) . Intracellular delivery of antimicrobial agents by liposomes has been demonstrated in experimental models of the intracellular parasitic infections leishmaniasis and malaria in hamsters and mice with intact host defense (1, 17, 20) , and of mycotic infections such as Candida albicans infection both in normal mice (16) and cyclophosphamide-treated mice (15) . Results of these studies demonstrated an improved therapeutic index and reduced toxicity resulting from encapsulation of the drug in liposomes. Liposomal entrapment of antibacterial drugs may also be interesting for the purpose of delivering the agents in relatively high concentrations into cells or specific tissues (22) . In our model of intracellular bacterial infection caused by L. monocytogenes, we demonstrated in mice with intact host defenses a considerable enhancement (80-fold) in the therapeutic activity of ampicillin resulting from liposomal encapsulation (3) . We speculated that the mechanism by which liposomes improve the therapeutic index of ampicillin in the treatment of listeriosis in mice is an increased delivery of the drug to macrophages of the liver and spleen. To determine whether the use of liposomes indeed resulted in an increased availability of the drug for the intracellular bacteria, we studied the effect of free versus liposome-entrapped ampicillin on the survival of L. monocytogenes within peritoneal mouse macrophages. We used macrophages because it is generally accepted that after intravenous inoculation in mice L. monocytogenes organ- isms reside within macrophages, especially of the liver and spleen (19) . We observed that ampicillin-containing liposomes are taken up by L. monocytogenes-infected cells. It is also well known from results of other in vitro studies that macrophages can take up liposomes very avidly (8, 21, 23, 27) . Uptake occurs predominantly by way of phagocytosis, followed by extensive degradation of the vesicles within the lysosomal compartment of the cells (9, 24 (14) . In contrast to the effect of 50 or 150 ,ug of free ampicillin per ml plus empty liposomes, a concentration of 50 ,g of free ampicillin plus 100 ,ug of liposome-entrapped ampicillin per ml killed 99% of the intracellular bacteria. The absence of any effect of empty liposomes on the number of intracellular bacteria, taken together with the observation that intact liposomes containing ampicillin were not bactericidal for L. monocytogenes, indicate that intracellular killing of bacteria is the result of cellular uptake of liposomes followed by liposomal release of ampicillin intracellularly.
Our results on the intracellular killing of L. monocytogenes by liposome-entrapped ampicillin in mice are in agreement with experiments of other investigators (4, 7, 10, 25) . Intracellular killing of Staphylococcus aureus in canine monocytes or in mouse peritoneal macrophages by aminoglycoside or dihydrostreptomycin, respectively (4, 10), and of E. coli in a macrophage cell line by streptomycin and chloramphenicol (25) was enhanced by encapsulating the drugs within liposomes. Desiderio and Campbell (7) showed the superiority of liposomal cephalothin to free cephalothin in effecting killing of the facultative intracellular bacterium Salmonella typhimurium.
From results of a previous study (3) we concluded that liposomal encapsulation of ampicillin results in a considerable enhancement in the therapeutic activity in the treatment of L. monocytogenes infection in mice by delivering the antibiotic in relatively high concentrations to the tissues infected with L. monocytogenes, the liver and spleen. Results of this study show that liposomal encapsulation of ampicillin results in an increased delivery of the antibiotic to the cells infected with L. monocytogenes, the macrophages, and an increased availability of ampicillin for the intracellular bacteria.
